View Item 

Show simple item record

Muscle atrophy in transgenic mice expressing a human TSC1 transgene

dc.contributor.authorWan, Minen_US
dc.contributor.authorWu, Xiaohuien_US
dc.contributor.authorGuan, Kun-Liangen_US
dc.contributor.authorHan, Minen_US
dc.contributor.authorZhuang, Yuanen_US
dc.contributor.authorXu, Tianen_US
dc.date.accessioned2016-01-04T20:52:06Z
dc.date.available2016-01-04T20:52:06Z
dc.date.issued2006-10-16en_US
dc.identifier.citationWan, Min; Wu, Xiaohui; Guan, Kun-Liang; Han, Min; Zhuang, Yuan; Xu, Tian (2006). "Muscle atrophy in transgenic mice expressing a human TSC1 transgene." FEBS Letters 580(24): 5621-5627.en_US
dc.identifier.issn0014-5793en_US
dc.identifier.issn1873-3468en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/116374
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherMuscular atrophyen_US
dc.subject.otherMouseen_US
dc.subject.otherTuberous sclerosis 1en_US
dc.subject.otherTransgenesisen_US
dc.titleMuscle atrophy in transgenic mice expressing a human TSC1 transgeneen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumLife Sciences Institute, Department of Biological Chemistry, and Institute of Gerontology, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherInstitutes of Biomedical Sciences, Fudan University, 220 Handan Road, Shanghai 200433, Chinaen_US
dc.contributor.affiliationotherInstitute of Developmental Biology and Molecular Medicine, Morgan-Tan International Center for Life Sciences, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200433, Chinaen_US
dc.contributor.affiliationotherHoward Hughes Medical Institute and Department of Genetics, Yale University School of Medicine, New Haven, CT, USAen_US
dc.contributor.affiliationotherDepartment of Immunology, Duke University Medical Center, Durham, NC, USAen_US
dc.contributor.affiliationotherHoward Hughes Medical Institute and Department of MCDB, University of Colorado at Boulder, Boulder, CO, USAen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/116374/1/feb2s0014579306010866.pdf
dc.identifier.doi10.1016/j.febslet.2006.09.008en_US
dc.identifier.sourceFEBS Lettersen_US
dc.identifier.citedreferenceX. Gao, Y. Zhang, P. Arrazola, O. Hino, T. Kobayashi, R.S. Yeung, B. Ru, D. Pan, Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol., 4,( 2002 ), 699 – 704.en_US
dc.identifier.citedreferenceS.C. Bodine, Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol., 3,( 2001 ), 1014 – 1019.en_US
dc.identifier.citedreferenceX.D. Peng, Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev., 17,( 2003 ), 1352 – 1365.en_US
dc.identifier.citedreferenceM. Ohanna, Atrophy of S6K1(−/−) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat. Cell Biol., 7,( 2005 ), 286 – 294.en_US
dc.identifier.citedreferenceJ. Young, S. Povey, The genetic basis of tuberous sclerosis. Mol. Med. Today, 4,( 1998 ), 313 – 319.en_US
dc.identifier.citedreferenceC.J. Potter, H. Huang, T. Xu, Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell, 105,( 2001 ), 357 – 368.en_US
dc.identifier.citedreferenceC.J. Potter, L.G. Pedraza, T. Xu, Akt regulates growth by directly phosphorylating Tsc2. Nat. Cell Biol., 4,( 2002 ), 658 – 665.en_US
dc.identifier.citedreferenceK. Inoki, Y. Li, T. Zhu, J. Wu, K.L. Guan, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol., 4,( 2002 ), 648 – 657.en_US
dc.identifier.citedreferenceB.D. Manning, A.R. Tee, M.N. Logsdon, J. Blenis, L.C. Cantley, Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell, 10,( 2002 ), 151 – 162.en_US
dc.identifier.citedreferenceK.S. Au, J.A. Rodriguez, J.L. Finch, K.A. Volcik, E.S. Roach, M.R. Delgado, E. Rodriguez Jr., H. Northrup, Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Am. J. Hum. Genet., 62,( 1998 ), 286 – 294.en_US
dc.identifier.citedreferenceK. Inoki, Y. Li, T. Xu, K.L. Guan, Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev., 17,( 2003 ), 1829 – 1834.en_US
dc.identifier.citedreferenceA. Garami, Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell, 11,( 2003 ), 1457 – 1466.en_US
dc.identifier.citedreferenceY. Zhang, X. Gao, L.J. Saucedo, B. Ru, B.A. Edgar, D. Pan, Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol., 5,( 2003 ), 578 – 581.en_US
dc.identifier.citedreferenceM. van Slegtenhorst, Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum. Mol. Genet., 7,( 1998 ), 1053 – 1057.en_US
dc.identifier.citedreferenceG. Benvenuto, The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene, 19,( 2000 ), 6306 – 6316.en_US
dc.identifier.citedreferenceH.C. Dan, Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem., 277,( 2002 ), 35364 – 35370.en_US
dc.identifier.citedreferenceL.D. Aicher, J.S. Campbell, R.S. Yeung, Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. J. Biol. Chem., 276,( 2001 ), 21017 – 21021.en_US
dc.identifier.citedreferenceK. Inoki, T. Zhu, K.L. Guan, TSC2 mediates cellular energy response to control cell growth and survival. Cell, 115,( 2003 ), 577 – 590.en_US
dc.identifier.citedreferenceJ.E. Johnson, B.J. Wold, S.D. Hauschka, Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol. Cell Biol., 9,( 1989 ), 3393 – 3399.en_US
dc.identifier.citedreferenceQ.T. Nguyen, A.S. Parsadanian, W.D. Snider, J.W. Lichtman, Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science, 279,( 1998 ), 1725 – 1729.en_US
dc.identifier.citedreferenceM.A. Shield, H.S. Haugen, C.H. Clegg, S.D. Hauschka, E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice. Mol. Cell Biol., 16,( 1996 ), 5058 – 5068.en_US
dc.identifier.citedreferenceG. Pallafacchina, E. Calabria, A.L. Serrano, J.M. Kalhovde, S. Schiaffino, A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl. Acad. Sci. USA, 99,( 2002 ), 9213 – 9218.en_US
dc.identifier.citedreferenceA.M. Fernandez, Functional inactivation of the IGF-1 and insulin receptors in skeletal muscle cause Type 2 diabetes. Genes Dev., 15,( 2001 ), 1926 – 1934.en_US
dc.identifier.citedreferenceJ.C. Bruning, M.D. Michael, J.N. Winnay, T. Hayashi, D. Horsch, D. Accili, L.J. Goodyear, C.R. Kahn, A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell, 2,( 1998 ), 559 – 569.en_US
dc.identifier.citedreferenceS. Fletcher, K. Honeyman, A.M. Fall, P.L. Harding, R.D. Johnsen, S.D. Wilton, Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide. J. Gene Med., 8,( 2006 ), 207 – 216.en_US
dc.identifier.citedreferenceJ. Dong, D. Pan, Tsc2 is not a critical target of Akt during normal Drosophila development. Genes Dev., 18,( 2004 ), 2479 – 2484.en_US
dc.identifier.citedreferenceX. Gao, D. Pan, TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev., 15,( 2001 ), 1383 – 1392.en_US
dc.identifier.citedreferenceN. Ito, G.M. Rubin, gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell, 96,( 1999 ), 529 – 539.en_US
dc.identifier.citedreferenceD.J. Glass, Molecular mechanisms modulating muscle mass. Trends Mol. Med., 9,( 2003 ), 344 – 350.en_US
dc.identifier.citedreferenceT.N. Stitt, The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell, 14,( 2004 ), 395 – 403.en_US
dc.identifier.citedreferenceM. Sandri, Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 117,( 2004 ), 399 – 412.en_US
dc.identifier.citedreferenceC. Rommel, S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, T.N. Stitt, G.D. Yancopoulos, D.J. Glass, Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol., 3,( 2001 ), 1009 – 1013.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
feb2s0014579306010866.pdf
Size:
696.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.